Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2008 Annual Meeting | Patient Safety Colloquium: Essential Patient Safety for the Neurologist - Does Your Practice Measure Up?

Sunday 04/13/08
09:00 AM - 12:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Colloquium
Michael J. Kaminski, MD, FÂ鶹´«Ã½Ó³»­
Participants should be able to demonstrate awareness of the key role of measurement in neurology patient safety; know key essential safety measures to be monitored at each patient encounter; understand ongoing patient safety activities in an innovative residency training program; be aware of monitoring safety issues in hospital stroke patients; understand the current and future role of third-party payers in evaluating patient safety; and be aware of updated online Â鶹´«Ã½Ó³»­ tools available to implement patient safety strategies now.
No CME available
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice
Introductory
Practitioner, Fellow, Resident, Nurse, Other
Event Timeline
09:00 AM - 09:30 AM Measurement: An Essential Step in Patient Safety
Daniel M. Feinberg, MD, FÂ鶹´«Ã½Ó³»­
09:30 AM - 09:55 AM The Essential Patient Safety Checklist
Michael J. Kaminski, MD, FÂ鶹´«Ã½Ó³»­
09:55 AM - 10:25 AM Measure Patient Safety in Residency Training
Eric M. McDade, DO, Brian C. Salter, MD
10:25 AM - 10:40 AM Break
10:40 AM - 11:05 AM Patient Safety in Hospital Stroke Care
Robert G. Holloway, MD, MPH, FÂ鶹´«Ã½Ó³»­
11:05 AM - 11:30 AM The Payer Perspective on Neurology Patient Safety
David A. Stumpf, MD, PhD, FÂ鶹´«Ã½Ó³»­
11:30 AM - 12:00 PM Finding the Tools to Help You Measure Patient Safety in Your Practice
Robert M. Kropp, MD, FÂ鶹´«Ã½Ó³»­
Faculty Disclosures
Robert G. Holloway, MD, MPH, FÂ鶹´«Ã½Ó³»­ Dr. Holloway has nothing to disclose.
Michael J. Kaminski, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Robert M. Kropp, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kropp has stock in RxLive, LLC. Dr. Kropp has a non-compensated relationship as a Investor with RxLive that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Daniel M. Feinberg, MD, FÂ鶹´«Ã½Ó³»­ Dr. Feinberg has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Hospitals.
Brian C. Salter, MD No disclosure on file
David A. Stumpf, MD, PhD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Eric M. McDade, DO Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. McDade has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alzamend. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. The institution of Dr. McDade has received research support from NIA. The institution of Dr. McDade has received research support from Eli Lilly. The institution of Dr. McDade has received research support from Eisai. The institution of Dr. McDade has received research support from Alzheimer's Association. Dr. McDade has received intellectual property interests from a discovery or technology relating to health care. Dr. McDade has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board Member with Fondation Alzheimer.